Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Starbucks
SBUX
|
$668M |
| 2 |
Vale
VALE
|
$335M |
| 3 |
CELG
Celgene Corp
CELG
|
$333M |
| 4 |
Amazon
AMZN
|
$310M |
| 5 |
CME Group
CME
|
$285M |
Top Sells
| 1 |
Apple
AAPL
|
$435M |
| 2 |
Meta Platforms (Facebook)
META
|
$358M |
| 3 |
Crown Castle
CCI
|
$266M |
| 4 |
Schlumberger
SLB
|
$231M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$190M |
Sector Composition
| 1 | Healthcare | 16.17% |
| 2 | Technology | 14.43% |
| 3 | Consumer Discretionary | 10.61% |
| 4 | Financials | 10.51% |
| 5 | Real Estate | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
VeriSign
VRSN
$25.5B
| $1.33B | 1.21% | 7,330,876 +299,876 | +4% | +$54.4M |
|
2
Novo Nordisk
NVO
$251B
| $1.12B | 1.02% | 21,344,916 +600,345 | +3% | +$31.4M |
|
3
Palo Alto Networks
PANW
$127B
| $1.09B | 0.99% | 4,484,150 +179,700 | +4% | +$43.6M |
|
4
Chipotle Mexican Grill
CMG
$56.5B
| $1.04B | 0.94% | 1,460,399 +219,940 | +18% | +$156M |
|
5
Vertex Pharmaceuticals
VRTX
$100B
| $934M | 0.85% | 5,078,717 +744,417 | +17% | +$137M |
|
6
PepsiCo
PEP
$204B
| $881M | 0.8% | 7,188,514 -91,736 | -1% | -$11.2M |
|
7
Humana
HUM
$36.5B
| $828M | 0.75% | 3,111,000 -396,800 | -11% | -$106M |
|
|
VMW
8
DELISTED
VMware, Inc
VMW
| $827M | 0.75% | 4,582,800 -450,668 | -9% | -$81.4M |
|
|
9
Starbucks
SBUX
$100B
| $823M | 0.75% | 11,073,986 +8,988,102 | +431% | +$668M |
|
10
Duke Energy
DUK
$95.3B
| $734M | 0.67% | 8,156,229 -53,550 | -0.7% | -$4.82M |
|
11
Domino's
DPZ
$15.6B
| $716M | 0.65% | 2,773,500 -312,000 | -10% | -$80.5M |
|
12
Amgen
AMGN
$155B
| $667M | 0.61% | 3,508,583 -70,017 | -2% | -$13.3M |
|
|
13
Meta Platforms (Facebook)
META
$1.86T
| $643M | 0.58% | 3,858,696 -2,150,666 | -36% | -$358M |
|
14
Align Technology
ALGN
$10.3B
| $643M | 0.58% | 2,260,000 -259,481 | -10% | -$73.8M |
|
15
GSK
GSK
$79.9B
| $596M | 0.54% | 14,272,600 +2,630,200 | +23% | +$110M |
|
16
Bristol-Myers Squibb
BMY
$96B
| $589M | 0.54% | 12,351,175 +5,404,300 | +78% | +$258M |
|
|
ABMD
17
DELISTED
Abiomed Inc
ABMD
| $589M | 0.54% | 2,060,923 +191,200 | +10% | +$54.6M |
|
18
Petrobras
PBR
$79.9B
| $553M | 0.5% | 34,718,800 +8,429,500 | +32% | +$134M |
|
19
BP
BP
$90.8B
| $532M | 0.48% | 12,166,246 +803,600 | +7% | +$35.1M |
|
20
Gilead Sciences
GILD
$140B
| $528M | 0.48% | 8,120,248 +2,730,700 | +51% | +$178M |
|
21
Molina Healthcare
MOH
$9.8B
| $525M | 0.48% | 3,695,205 -294,350 | -7% | -$41.8M |
|
22
Progressive
PGR
$145B
| $521M | 0.47% | 7,226,596 -604,800 | -8% | -$43.6M |
|
23
Ralph Lauren
RL
$18B
| $510M | 0.46% | 3,934,994 +348,794 | +10% | +$45.2M |
|
|
24
Crown Castle
CCI
$43.2B
| $500M | 0.45% | 3,903,300 -2,079,403 | -35% | -$266M |
|
|
MOMO
25
Hello Group
MOMO
$1.33B
| $494M | 0.45% | 12,927,803 +1,482,100 | +13% | +$56.7M |
|